Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity

Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity have?

Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity has 133 citations in the OpenAlex counts ScholarIQ stores.

When was Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity published?

Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity has 2009 year in the ScholarIQ index.

What is the open-access status of Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity?

Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity has closed oa status in the ScholarIQ index.

What is the DOI of Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity?

The DOI for Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity is on the source record.

What is the PMID of Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity?

The PMID for Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity is on the source record.

What is the OpenAlex record for Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity?

The OpenAlex for Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity is on the source record.